Clinical Study
Pancreatic Resections for Advanced M1-Pancreatic Carcinoma: The Value of Synchronous Metastasectomy
Table 1
Clinicopathologic characteristics (M1-Patients).
| | Variable | No. of patients (%) () |
| | Patient characteristics | | | Mean age ± SD | 58.4 ± 11.8 | | Sex ( men) | 9 (45) | | Median tumor size (cm) | 4.1 (1–11) | | Lymph node disease | 16 (80) | | Origin of tumor | | | Pancreas head | 9 (45) | | Pancreas corpus/tail | 9 (45) | | Papilla | 2 (10) | | Hepatic metastasis | 14 (70) | | Preoperative known | 9 (45) | | unknown | 5 (25) | | Median size of largest metastasis (cm) | 1,6 (0,5–4,0) | | Solitary metastases | 5 (25) | | Other metastases | | | Peritoneum | 5 (25) | | Omentum majus | 2 (10) | | Lymphnodes | 4 (20) | | Adjuvant chemotherapy | 20 (100) | | (+neoadjuvant chemotherapy) | 2 (10) | | Median survival (months) | 10.7 (2.6–37.8) |
|
|
